122 related articles for article (PubMed ID: 38507608)
1. Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial.
Plechschmidt J; Fietkau K; Hepp T; Dietrich P; Fischer S; Krebs S; Neurath MF; Dörje F; Atreya R
Inflamm Bowel Dis; 2024 Mar; ():. PubMed ID: 38507608
[TBL] [Abstract][Full Text] [Related]
2. Effect of Physician-Pharmacist Participation in the Management of Ambulatory Cancer Pain Through a Digital Health Platform: Randomized Controlled Trial.
Zhang L; McLeod HL; Liu KK; Liu WH; Huang HX; Huang YM; Sun SS; Chen XP; Chen Y; Liu FZ; Xiao J
JMIR Mhealth Uhealth; 2021 Aug; 9(8):e24555. PubMed ID: 34398796
[TBL] [Abstract][Full Text] [Related]
3. Sex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease.
Zelinkova Z; Bultman E; Vogelaar L; Bouziane C; Kuipers EJ; van der Woude CJ
World J Gastroenterol; 2012 Dec; 18(47):6967-73. PubMed ID: 23322995
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Impact of a pharmacist-led thiopurine monitoring service in outpatients with inflammatory bowel disease.
Rodda SE; Fildes KJ; Shelton E; Goldberg R; Moore GT
Intern Med J; 2023 May; 53(5):779-786. PubMed ID: 35603759
[TBL] [Abstract][Full Text] [Related]
6. Effect of a Multifaceted Clinical Pharmacist Intervention on Medication Safety After Hospitalization in Persons Prescribed High-risk Medications: A Randomized Clinical Trial.
Gurwitz JH; Kapoor A; Garber L; Mazor KM; Wagner J; Cutrona SL; Singh S; Kanaan AO; Donovan JL; Crawford S; Anzuoni K; Konola TJ; Zhou Y; Field TS
JAMA Intern Med; 2021 May; 181(5):610-618. PubMed ID: 33646267
[TBL] [Abstract][Full Text] [Related]
7. The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents.
Dürr P; Schlichtig K; Kelz C; Deutsch B; Maas R; Eckart MJ; Wilke J; Wagner H; Wolff K; Preuß C; Brückl V; Meidenbauer N; Staerk C; Mayr A; Fietkau R; Goebell PJ; Kunath F; Beckmann MW; Mackensen A; Neurath MF; Pavel M; Dörje F; Fromm MF
J Clin Oncol; 2021 Jun; 39(18):1983-1994. PubMed ID: 33822650
[TBL] [Abstract][Full Text] [Related]
8. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial.
Crotty M; Rowett D; Spurling L; Giles LC; Phillips PA
Am J Geriatr Pharmacother; 2004 Dec; 2(4):257-64. PubMed ID: 15903284
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance.
Fornasier G; Taborelli M; Francescon S; Polesel J; Aliberti M; De Paoli P; Baldo P
Int J Clin Pharm; 2018 Aug; 40(4):795-802. PubMed ID: 29785683
[TBL] [Abstract][Full Text] [Related]
10. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohn's Disease and Ulcerative Colitis.
Tiao DK; Chan W; Jeganathan J; Chan JT; Perry J; Selinger CP; Leong RW
Inflamm Bowel Dis; 2017 Aug; 23(8):1257-1261. PubMed ID: 28719539
[TBL] [Abstract][Full Text] [Related]
12. Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study.
Wongpakaran R; Suansanae T; Tan-Khum T; Kraivichian C; Ongarjsakulman R; Suthisisang C
J Clin Pharm Ther; 2017 Jun; 42(3):329-336. PubMed ID: 28317138
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
15. Impact of medication reconciliation and review and counselling, on adverse drug events and healthcare resource use.
Al-Hashar A; Al-Zakwani I; Eriksson T; Sarakbi A; Al-Zadjali B; Al Mubaihsi S; Al Za'abi M
Int J Clin Pharm; 2018 Oct; 40(5):1154-1164. PubMed ID: 29754251
[TBL] [Abstract][Full Text] [Related]
16. Impact of clinical pharmacist-led intervention for drug-related problems in neonatal intensive care unit a randomized controlled trial.
Yalçın N; Kaşıkcı M; Çelik HT; Allegaert K; Demirkan K; Yiğit Ş
Front Pharmacol; 2023; 14():1242779. PubMed ID: 37645440
[No Abstract] [Full Text] [Related]
17. Impact of pharmacist educational intervention on disease knowledge, rehabilitation and medication adherence, treatment-induced direct cost, health-related quality of life and satisfaction in patients with rheumatoid arthritis: study protocol for a randomized controlled trial.
Naqvi AA; Hassali MA; Naqvi SBS; Aftab MT
Trials; 2019 Aug; 20(1):488. PubMed ID: 31399128
[TBL] [Abstract][Full Text] [Related]
18. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial.
Martin P; Tamblyn R; Benedetti A; Ahmed S; Tannenbaum C
JAMA; 2018 Nov; 320(18):1889-1898. PubMed ID: 30422193
[TBL] [Abstract][Full Text] [Related]
19. Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy.
Thomas PWA; Römkens TEH; West RL; Russel MGVM; Jansen JM; van Lint JA; Jessurun NT; Hoentjen F
United European Gastroenterol J; 2021 Oct; 9(8):919-928. PubMed ID: 34077634
[TBL] [Abstract][Full Text] [Related]
20. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
Altavela JL; Jones MK; Ritter M
J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
